WHAT IS AGE-RELATED MACULAR DEGENERATION (AMD)?

A combination of antioxidants, such as vitamins C and E,as well as Lutein, Zeaxanthi and zinc, can help to slow the progression of AMD.

Anti-VEGF injections can help to reduce the growth of new blood vessels in the eye, which can cause vision loss in people with AMD.

Laser therapy can help to destroy abnormal blood vessels in the eye that can cause vision loss in people with AMD.

Photodynamic therapy uses a light-activated drug to destroy abnormal blood vessels in the eye.

Smoking, age, genetic predisposition and chronic exposure to sunlight are considered the most significant risk factors for getting AMD.

Difficulty seeing under low light conditions or at night is one of the first symptoms of AMD. Studies have shown that loss of photoreceptor cells (in the macula), particularly 'rod cells' involved in night vision, occurs before structural markers of AMD are visible.

Currently, scientific studies cannot definitively say that light intensities (of any colour) coming from digital devices pose a significant threat to our retinas. But, this hasn't been ruled out, so the general advice is moderate and manage excessive screen time.

It is generally accepted that wearing sunglasses in bright sunlight reduces oxidative stress in the retina.

The AREDS studies were designed to investigate the effects of supplements on patients that had already developed AMD – read about it below. Several antioxidants can neutralise the oxygen by-product, thereby reducing cell oxidative stress. Your body, for example, is programmed to produce glutathione (an antioxidant) in all cells to balance oxidative stress. Other essential antioxidants include vitamin C, vitamin E and carotenes. However, these cannot be made by our bodies and need to be taken up through diet - the food we and any supplements we take.

The Age-Related Eye Disease Study (AREDS) and AREDS2 were two large clinical studies with several thousand participants conducted over many years. The studies were designed to investigate the effects of supplements (including Lutein, Zeaxanthin, antioxidants and zinc) on patients already developing AMD. The final results and follow-up studies identified benefits for some patients. The AREDS2 formulation has been widely adopted by specialists and doctors in delaying or slowing down the progression of AMD.

People who regularly consume a Mediterranean-like diet are at a lower risk than those who consume a traditional Western diet, including high glycemic index foods, high-fat dairy products, fried foods, and processed meats. Exercising regularly and wearing sunglasses with good UV protection may also prevent or delay the progression of AMD.

Reactive oxygen species are created as a by-product whenever cells consume oxygen. The damage that’s caused by this by-product is called oxidative stress. The macula requires a lot of energy (due to the enormous amount of visual information processed in this small piece of tissue). Consequently, the macula uses a lot of oxygen, which causes oxidative stress.

Any exposure to light causes oxidative stress (especially to the macula). Our cells have in-built mechanisms to defend against oxidative stress. Still, it is suggested that as we age, our defence mechanisms weaken, exposing our cells to more oxidative stress. Hence, oxidative stress is considered a contributing factor to the onset of AMD.

AMD is the leading cause of adult blindness in developed countries, particularly in those over 55 years of age. Worldwide, this condition accounts for 7% of cases of blindness and is expected to affect 288 million people by 2040. AMD is more prevalent than glaucoma and dry eye combined.